Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Comparisons, in Myeloma Patients of All Ages, of Thalidomide, Lenalidomide, Carfilzomib and Bortezomib Induction Combinations, and of Lenalidomide and Combination Lenalidomide Vorinostat as Maintenance (Myeloma XI)

NCT01554852 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT01554852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01554852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Comparisons, in Myeloma Patients of All Ages, of Thalidomide, Lenalidomide, Carfilzomib and Bortezomib Induction Combinations, and of Lenalidomide and Combination Lenalidomide Vorinostat as Maintenance (Myeloma XI)
Lead sponsor
University of Leeds
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2010
Completion date
December 31, 2022
Enrollment
4,420 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma